Smith, LaGrange want federal health minister to back off after expressing dual-practice concerns - Medicine Hat News

Minister of Hospital and Surgical Health Services, Adriana LaGrange, who is also the MLA for Red Deer-North, will travel to Europe this week to learn more about innovative health care models and how they can improve access and outcomes for Albertans. LaGrange will be gone from Oct. 2-10 in Sweden and Denmark. In a release, it’s noted she will visit world-class medical facilities, including Karolinska University Hospital and Zealand University Hospital. “Albertans deserve a modern, responsive health care system that puts patients first,” says LaGrange.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.